The DBEI distinctively brings together expertise in biostatistics, epidemiology and informatics, to advance population-health science.
Home
Featured Event
4th Penn Conference on Big Data in Biomedical & Population Health Sciences
September 16-17, 2024 | Gaulton Auditorium/Lobby, Biomedical Research Building (421 Curie Boulevard, Philadelphia, PA)
Announcements
Sandra (Sandy) LaMonaca brings experience and dedication to her role as Associate Director of Academic Operations in the Department of Biostatistics, Epidemiology, and Informatics (DBEI). A Philadelphia native, Sandy returned in 2014 after a career spanning both government and corporate sectors in New Jersey and Connecticut, since 1997.
At Penn's School of Veterinary Medicine, Sandy served the Office of the Chair for the Department of Clinical Sciences and Advanced Medicine (CSAM), where she managed all faculty activities for over 70 clinical faculty in a 24/7 level-one small animal hospital trauma center. Her span included the streamlining of numerous operational processes and steadfast support for faculty and staff alike.
With a formal education in Business Administration and BAAS in Leadership & Communication, Sandy's career has been marked by resilience and multifaceted skill sets. Her journey includes a 14-year tenure as a volunteer firefighter in New Jersey, achieving certifications in Firefighter I & II, EMT, CPR, Instructor as well as leadership and incident command training. These experiences have uniquely equipped Sandy with the ability to thrive in high-pressure environments and excel in problem-solving, project management, and service to others — skills she seamlessly translates into her academic operations role.
Outside of work, Sandy shares her home in West Deptford, NJ with her husband Jim, who works for Penn Vet, their children, and their four dogs. Nestled on a wooded property, they find joy in the company of nature and animals, enjoying their shared passion for cooking, travel, entertaining friends, and simply being together as a family.
Sandy LaMonaca's journey is a testament to the power of diverse experiences and a deep-rooted commitment to excellence, both professionally and personally. Her ability to blend leadership, compassion, and strategic acumen enriches the academic community at Penn, inducing her drive and passion for every endeavor she undertakes.
Aug. 1, 2024. Please join us in welcoming new primary faculty members, Angela Aherrera, DrPH, MPH and Brielin Brown, PhD to the Department of Biostatistics, Epidemiology and Informatics!
Dr. Aherrera joins the department as an Assistant Professor of Epidemiology. She is an environmental epidemiologist, whose research focuses on environmental hazards and understanding their role in the development and prevention of adverse respiratory health outcomes. As a NIEHS-FDA K99/R00 grantee, she is currently investigating the exposure and toxicity of metal and aldehydes, as well as the pulmonary health effects, including inflammation, of using new and emerging electronic cigarette devices among young adults. She is also interested in airborne microplastics and was awarded NIOSH pilot funding to assess occupational exposures to microfibers—a common type of microplastic—among garment industry workers.
As a NIEHS-FDA K99/R00 grantee, Dr. Aherrera is investigating the exposure and toxicity of metal and aldehydes, as well as the pulmonary health effects, including inflammation, of using electronic cigarettes among young adults. She is also interested in airborne microplastics and was awarded NIOSH funding to assess occupational exposure to microfibers—a common type of microplastic—among garment industry workers. Ultimately, Dr. Aherrera’s goals are to contribute to reducing environmental health inequities in vulnerable and disproportionately exposed populations.
She received a DrPH (2019) and MPH (2015) from the Johns Hopkins Bloomberg School of Public Health before assuming the role of a postdoctoral fellow in the school's Department of Environmental Health and Engineering.
Dr. Brown joins the department as an Assistant Professor of Informatics and Genetics and is broadly interested in the development and application of statistical and computational methods in bioinformatics and genetics with a focus on complex traits. He is particularly interested in large-scale exploratory data analysis, causal inference, omics data integration, and cross-ancestry analysis. Dr. Brown and his research group employ techniques to analyze medically linked genetic and multi-omic studies, single-cell sequencing, and CRISPR-based screen data with the goal of understanding the mechanism of complex and common diseases. The long-term goal of his research group is to build large-scale, causally grounded, multifactorial disease models that can be used to predict intervention effects, identify key pathways, and enable precision medicine.
He received a PhD from the Department of Computer Science at the University of California, Berkeley (2016) before working as a computational biologist at Verily Life Sciences. In 2019, he returned to academia as a Data Science Institute fellow at Columbia University and a postdoctoral fellow at the New York Genome Center.
In the News
Joel Gelfand, MD, the James J. Leyden, M.D. Endowed Professor in Clinical Investigation of Dermatology and Epidemiology, and colleagues at Penn found that adults and children with atopic dermatitis (AD) are more likely to develop inflammatory bowel disease (IBD) than their peers. In a new study published in the journal JAMA Dermatology, Dr. Gelfand and his team compared data from more than 409,000 children and 625,000 adults with atopic dermatitis and compared them to more than 1.8 million children and almost 2.7 million adults without the disease. Upon analysis, the scientists reported a “statistically significant” increased risk of incident or new-onset IBD among 44% of children and 34% of adults with atopic dermatitis, compared to the control groups.
"Less work has been done with atopic dermatitis, which is a very common skin disorder, and IBD. Both atopic dermatitis and IBD are diseases with barrier dysfunction, microbiome alterations, and chronic inflammation suggesting commonalities between the two diseases,” said Dr. Gelfand in a recent interview with Medical News Today. According to Dr. Gelfand, these findings are important for better understanding the health trajectories of people with atopic dermatitis.
Elizabeth Nesoff, PhD, MPH discusses her recently published study in the Leonard Davis Institute of Health Economics (LDI) blog investigating neighborhood features that were correlated with fatal opioid overdoses among the homeless population in New York City. Dr. Nesoff uses these discoveries to make important policy recommendations with respect to targeted outreach and other interventions.
Jeffrey Morris, PhD and Jeffrey Gerber, MD, PhD, MSCE collaborated with researchers to examine measles serostatus among pregnant persons about to give birth and whether rubella serostatus, which is routinely assessed during pregnancy, can serve as a proxy for measles serostatus.
About Us
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics.
© 2023 Trustees of the University of Pennsylvania. All rights reserved.. | Disclaimer